13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico

Update Il y a 4 ans
Reference: NCT01432262

Woman and Man

  • | Country :
  • Mexico
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study will be to assess the safety, tolerability, and immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) when given to healthy adults older than 50 years of age who haven't received 23-valent pneumococcal polysaccharide vaccine in Mexico.


Inclusion criteria

  • Pneumococcal Infections

Links